SpringerLink
Log in

Washout of I-123 meta-iodobenzylguanidine for assessing cardiac sympathetic activity with progression of hypertension in Dahl salt-sensitive rats

  • Original Articles
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

To evaluate cardiac sympathetic activity, a simple method should be developed to replace such complex methods as the spillover rate of tritiated norepinephrine (3H-norepinephrine) or microneurography of sympathetic nerve activity. The goal of this study is to evaluate cardiac sympathetic activities by analyzing the washout of I-123 meta-iodobenzylguanidine (123I-MIBG), a radiolabeled norepinephrine analogue, in Dahl salt-sensitive (DS) rats as it relates to the progression of hypertension.

Methods and Results

Dahl salt-resistant (DR) rats and DS rats were fed an 8% salt diet starting at age 5 weeks. Marked hypertension and cardiac hypertrophy developed in the DS rats, whereas DR rats remained normotensive. Then the time-activity curves of 123I-MIBG from 15 to 200 minutes were obtained from both DS and DR strains at ages 8, 11, and 13 weeks using dynamic scintigraphic analysis. We also examined the nonneuronal washout of 123I-MIBG using dynamic scintigraphic studies in desipramine pretreated normal rats. In the preliminary study with desipramine pretreatment, the majority of the nonneuronal 123I-MIBG washout occurred by 90 minutes after injection. Therefore the late-phase washout in the control rats was found to reflect the neuronal washout. We then applied exponential curve fitting to the time activity curves acquired in the 90- to 200-minute period after 123I-MIBG injection in both DR and DS rats. When we compared the coefficients of these washout curves in the DS and DR rats as an index of cardiac sympathetic activities, the coefficient values remained high during all stages in DS rats, whereas they decreased with age in DR rats.

Conclusion

Measurement of late-phase 123I-MIBG washout may be a useful tool for assessing the change in sympathetic activity in the progression of hypertension without the influence of extraneuronal washout of 123I-MIBG and left ventricular hypertrophy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dae MW, Herre JM, O'Connel JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416–23.

    Article  PubMed  CAS  Google Scholar 

  2. Stanton MS, Tuli MM, Radtke NL, Heger JJ, Miles WM, Mock BH, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using 123I-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519–26.

    Article  PubMed  CAS  Google Scholar 

  3. Dae MW, De Marco T, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med 1992;33:1444–50.

    PubMed  CAS  Google Scholar 

  4. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive heart failure and cardiac transplants. J Nucl Med 1989;30:1182–91.

    PubMed  CAS  Google Scholar 

  5. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625–36.

    PubMed  CAS  Google Scholar 

  6. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620–4.

    PubMed  CAS  Google Scholar 

  7. Dae MW, O'Connell JW, Botvinick EH, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 1995;30:270–80.

    PubMed  CAS  Google Scholar 

  8. Jacques S, Tobes MC, Sisson JC, Baker JA, Wieland DM. Comparison of the sodium dependency of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 1984;26:539–46.

    Google Scholar 

  9. Glowniak JV. Cardiac studies with metaiodobenzylguanidine: a critique of methods and interpretation of results. J Nucl Med 1995;36:2133–7.

    PubMed  CAS  Google Scholar 

  10. Takatsu H, Uno Y, Fujiwara H. Modulation of left ventricular iodine-125 MIBG accumulation in cardiomyopathic Syrian hamsters using the renin-angiotensin system. J Nucl Med 1995;36:1055–61.

    PubMed  CAS  Google Scholar 

  11. Takatsu H, Scheffel U, Fujiwara H. Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle—influence of immobilization stress and inhibition of the renin-angiotensin system. J Nucl Cardiol 1995;2:507–12.

    Article  PubMed  CAS  Google Scholar 

  12. Julius S. Autonomic nervous system dysregulation in human hypertension. Am J Cardiol 1991;67:3–7.

    Article  Google Scholar 

  13. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol 1992;20(suppl 8):40–8.

    Google Scholar 

  14. Widimsky J, Fejfarova MH, Fejfar Z. Changes of cardiac output in hypertensive disease. Cardiologia 1957;31:381–9.

    Article  PubMed  CAS  Google Scholar 

  15. Messerli FH, Frohlich ED, Suarez DH, Reisin E, Dreskinski GR, Dunn EG, et al. Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation 1981;64:760–4.

    PubMed  CAS  Google Scholar 

  16. Julius S, Conway J. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968;28:282–8.

    Google Scholar 

  17. Dahl LK, Heine M, Tassinari L. Effects of chronic salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 1962;115:1173–90.

    Article  PubMed  CAS  Google Scholar 

  18. Dahl LK, Knudsen KD, Heine MA, Leitl GJ. Effects of chronic excess salt ingestion: modification of experimental hypertension in the rat by variations in the diet. Circ Res 1968;22:11–8.

    PubMed  CAS  Google Scholar 

  19. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failed left ventricles in Dahl salt-sensitive rats. Am J Physiol 1994;267:2471–82.

    Google Scholar 

  20. Mock BH, Tuli MM. Influence of specific activity on myocardial uptake of 123I-MIBG in rats. Nucl Med Commun 1988;9:663–7.

    Article  PubMed  CAS  Google Scholar 

  21. Tobes MC, Jacques S, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodo-benzylguanidine. J Nucl Med 1985;26:897–907.

    PubMed  CAS  Google Scholar 

  22. Mancia G, Grassi G, Parati G, Daffonchio A. Evaluating sympathetic activity in human hypertension. J Hypertens 1993;11(suppl 5):13–9.

    Google Scholar 

  23. Esler M, Jennings G, Komer P, Willett I, Dudley F, Hastings G, et al. Assessment of human sympathetic nervous system activity from measurement of norepinephrine turnover. Hypertension 1988;11:3–20.

    PubMed  CAS  Google Scholar 

  24. Melet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Done P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471–7.

    Google Scholar 

  25. Nakajima K, Taki J, Tonami N, Hisada K. Decreased 123-I MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994;15:317–23.

    Article  PubMed  CAS  Google Scholar 

  26. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192–9.

    PubMed  CAS  Google Scholar 

  27. Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986;27:84–9.

    PubMed  CAS  Google Scholar 

  28. Rabinovitch MA, Rose CP, Schwab AJ, Fitchett DH, Honos GN, Stewart JA, et al. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993;34:589–600.

    PubMed  CAS  Google Scholar 

  29. Lurie KG, Dae MW, Dutton J, Velazquez-Roch SJ, O'Connell JW. Metaiodobenzylguanidine as an index of atrioventricular nodal adrenergic activity. J Nucl Med 1995;36:1096–101.

    PubMed  CAS  Google Scholar 

  30. Genain CP, Reddy S, Ott C, Van Loon GR, Kotchen TA. Failure of salt loading to inhibit tissue norepinephrine turnover in prehypertensive Dahl salt-sensitive rats. Hypertension 1988;12:568–73.

    PubMed  CAS  Google Scholar 

  31. Esler M, Jennings G, Bivano B, Lambert G, Hasking G. Mechanisms of elevated plasma noradrenaline in the cause of essential hypertension. J Cardiovasc Pharmacol 1986;8(suppl 5):39–44.

    Article  Google Scholar 

  32. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989; 2:140–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Daiichi Radioisotope Labs, Chiba, Japan

    Minoru Inoue, Syusaku Tazawa, Hiroyuki Kurosawa & Kazuhiko Nishigaki

  2. The Second Department of Internal Medicine, Gifu University School of Medicine, 40 Tsukasamachi, 500, Gifu, Japan

    Hisato Takatsu, Toshiyuki Noda, Masazumi Arai, Akihisa Kunishima & Hisayoshi Fujiwara

Authors
  1. Hisato Takatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Noda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masazumi Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akihisa Kunishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Minoru Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Syusaku Tazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroyuki Kurosawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kazuhiko Nishigaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hisayoshi Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisato Takatsu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takatsu, H., Noda, T., Arai, M. et al. Washout of I-123 meta-iodobenzylguanidine for assessing cardiac sympathetic activity with progression of hypertension in Dahl salt-sensitive rats. J Nucl Cardiol 6, 204–210 (1999). https://doi.org/10.1016/S1071-3581(99)90081-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-3581(99)90081-8

Key Words

Search

Navigation